Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC

Clinical trial NCT06555133 · RECRUITING

Trial details

NCT number: NCT06555133
Sponsor: Brown University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Carcinoma Metastatic in the Liver

Start date: 2025-04-07
Primary completion: 2026-09-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.